Search the Newsreel

Medpace (MEDP) Beats Q2 Earnings and Revenue Estimates

Medpace (MEDP) came out with quarterly earnings of $4.25 per share, beating the Zacks Consensus Estimate of $4.08 per share. This compares to earnings of $3.1 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings …

Medpace Notches A Big Bookings Beat, And Reverses Its First-Quarter Malaise

Medpace Holdings stock surged by double digits late Wednesday, helped by a big bookings beat, rebounding from a poor start to the year. Then, the book-to-bill ratio came in at 0.88x and Medpace stock plummeted to a nine-month low. In after-hours trades on the …

Medpace surges on earnings beat and raised guidance By Investing.com

Medpace Holdings Inc. (NASDAQ:MEDP) reported strong second-quarter results, beating analyst expectations for earnings and revenue. The clinical research organization also issued full-year 2026 guidance that surpassed consensus estimates, leading to an 18.7% surge in shares during after-hours trading. The robust performance was driven by …

Medpace (NASDAQ:MEDP) Exceeds Q2 CY2026 Expectations, Stock Jumps 18.6%

Medpace Holdings (NASDAQ:MEDP) reported strong financial results for Q2 CY2026, with revenue of $707.3 million, exceeding analyst estimates by 2.6%. The company's GAAP EPS of $4.25 also beat consensus estimates by 6.6%. Following these positive results, Medpace raised its full-year revenue guidance to $2.85 …

Earnings Flash (MEDP) Medpace Holdings, Inc. Reports Q2 Revenue $707.3M, vs. FactSet Est of $689.5M

Medpace Holdings, Inc. (MEDP) announced Q2 revenue of $707.3 million, surpassing FactSet's estimate of $689.5 million. The company also anticipates full-year 2026 revenue to be between $2.81 billion and $2.89 billion, exceeding FactSet's estimate of $2.77 billion. Additionally, Medpace reported Q2 EPS of $4.25, …

(MEDP) Medpace Expects Full Year 2026 EPS Range $17.25 - $17.95, vs. FactSet Est of $16.97

Medpace Holdings, Inc. (MEDP) has provided its earnings per share (EPS) guidance for the full year 2026, anticipating a range of $17.25 to $17.95. This forecast surpasses the current FactSet estimate of $16.97. The news follows Medpace's Q2 earnings report, which indicated a rise …

Medpace To Report Q2 Results; Can Growth Sustain After A Strong Start To 2026?

(RTTNews) - Medpace Holdings, Inc. (MEDP) will report second-quarter 2026 results on July 22, 2026, with investors watching whether the contract research organization can extend the robust growth it delivered in Q1 and maintain its elevated backlog conversion pace. Revenue in the first quarter …

MEDPACE HOLDINGS ($MEDP) Releases Q2 2026 Earnings, Stock Rises

Medpace stock trades near record levels as revenue and earnings accelerate

Medpace Holdings Inc. (MEDP) is experiencing strong growth, with its stock trading near record levels due to double-digit revenue expansion and rising profitability. The contract research organization reported a 22% revenue increase and a 28% EPS increase in Q1 2026, alongside a robust backlog …

What To Expect From Medpace’s (MEDP) Q2 Earnings

Medpace Holdings (MEDP) is set to report its Q2 earnings this Wednesday. The company previously exceeded revenue expectations in Q1, and analysts anticipate a 14.3% year-on-year revenue growth for Q2. Investor sentiment for life sciences tools & services stocks has been positive, with Medpace's …

Medpace Holdings Q2 2026 Earnings Preview — July 23, Street Expects $4.00 EPS

Medpace Holdings (MEDP) is expected to report strong double-digit growth for its Q2 2026 earnings on July 23, with analysts forecasting $4.00 EPS on $688.8 million in revenue. This represents a significant year-over-year increase in both earnings and revenue, driven by anticipated margin expansion …

ETFs Investing in Medpace Holdings, Inc. Stocks

This article lists various Exchange Traded Funds (ETFs) that hold stocks of Medpace Holdings, Inc. It details each fund's market value, weight of Medpace stock, issuer, management style, focus, expense ratio, assets under management (AUM), price, change percentage, relative volume, and 3-year NAV total …

MedPal AI shares slide despite raising £5m to fund growth aspirations

Dp Aircraft I Stock Price Forecast. Should You Buy DPA.L?